Kyntra Bio (KYNB) EPS (Diluted) (2014 - 2026)
Powered by 
Analysis
Kyntra Bio (KYNB) EPS (Diluted) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.71 Bn | 192.72 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.26 Bn | 177.08 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.29 Bn | 123.43 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.82 Bn | 73.83 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.94 Bn | 48.80 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.34 Bn | 30.03 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.87 Bn | 30.58 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.02 Bn | 29.02 Bn | 1.16 Mn | -0.40 |
| 10 | Kyntra Bio | 31.53 Mn | 31.53 Mn | 1.47 Mn | 2.96 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 |
| Mar 31, 2026 | -3.76 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | 49.61 |
| Jun 30, 2025 | -1.88 |
| Mar 31, 2025 | 1.15 |
| Dec 31, 2024 | 4.49 |
| Sep 30, 2024 | -4.25 |
| Jun 30, 2024 | -3.89 |
| Mar 31, 2024 | -8.32 |
| Dec 31, 2023 | -23.88 |
| Sep 30, 2023 | -16.36 |
| Jun 30, 2023 | -22.57 |
| Mar 31, 2023 | -20.46 |
| Dec 31, 2022 | -17.75 |
| Sep 30, 2022 | -24.54 |
| Jun 30, 2022 | -19.57 |
| Mar 31, 2022 | -17.07 |
| Dec 31, 2021 | -36.39 |
| Sep 30, 2021 | 13.32 |